Curing Cancer With AI: It’s Taking Shape
SMRTR summary
AI and new immune system therapies are revolutionizing cancer treatment by enabling earlier diagnosis and personalized medicine. Harvard researchers developed breakthrough "in vivo T cell engineering" that restores elderly immune systems to function like 20-year-olds, potentially eliminating cancer recurrence fears. This approach combines AI diagnostics with immune "hyperactivators" that rejuvenate aging dendritic cells and T cells, offering hope across all cancer types with clinical trials beginning next year.
SMRTR provides this summary for quick context. The original article belongs to Forbes.
Read the original article